Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

6.75
Delayed Data
As of Jul 27
 +0.15 / +2.27%
Today’s Change
4.32
Today|||52-Week Range
7.79
+5.63%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close6.60
Today’s open6.65
Day’s range6.60 - 6.80
Volume115,914
Average volume (3 months)100,336
Market cap$333.8M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-73.91%
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.99%
P/E ratioNM
Price/Sales34.74
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...-0.02-0.13%
BTXBioTime Inc+0.10+3.33%
NDRMNeuroderm Ltd+0.39+2.23%
EDGEEdge Therapeutics In...-0.12-1.20%
Data as of 4:02pm ET, 07/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$9.3M
Annual profit (last year)-$20.2M
Net profit margin-217.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Operating &
Financial Officer
Ari Krashin
Corporate headquarters
Holon, Tel Aviv

Forecasts

Partner Offers

Search for Jobs